top of page
AVG_T363 vil 229e 2.jpg

VIROGENETICS

Upper respiratory tract disease in cats

Upper respiratory tract inflammation disease (URTD) in cats, called "cat's runny nose", "cat flu", is a common disease whose symptoms include coughing, sneezing, runny nose, redness of the eyes, fever or the appearance of purulent secretions discharge from nose and eyes. Cat's runny nose. The main viral etiological factors of this disease are feline herpesvirus type 1 (FHV-1, FeHv-1) and feline calicivirus (FCV). 

The disease is considered as a one of the main causes of death in animal shelters and in catteries. The currently available antiviral agents for the treatment and/or prophylaxis of respiratory syndrome in cats that may be caused by viruses, such as FHV or FCV, are insufficiently effective and/or too toxic. There is therefore a need to find an effective therapeutic agent that will effectively efficiently reduce the infection and transmission of both viruses, while being safe for cats.

URTD in cats

Statistics

135079595_3649923355101616_1689977343469

The main goals

Shorter time of convalescence

Lower cats’ treatment cost

Fewer side effects

Improve the health of cats

The object of the invention is to obtain a new, effective active substance for use in the treatment and/or prophylaxis of cat flu’s runny nose, in particular infection caused by feline calicivirus or herpesvirus, in particular FHV-1 or FCV virus. The main goal is to obtain a new effective agent for use in treatment and/or prophylaxis of URTD in cats, especially infection caused by feline calicivirus or herpesvirus, which can be used in combination therapy with already available therapies for this type of infection, as well as demonstrating the possibility of using such a preparation for the treatment of this type of infection.

Meet The Team

5d6e39dc-8b10-5a3f-b4c1-900a554be199.jpg

Krzysztof Pyrć

Management Board

Aleksandra-Synowiec_2.jpg

Aleksandra Synowiec

Management Board

MN2[18021].tif

Maria Nowakowska

Supervisory Board

20210112_094350.jpg

Krzysztof Szczubiałka

Supervisory Board

bottom of page